Shin Nippon Biomedical Laboratories, Ltd.
Research Shin Nippon Biomedical Laboratories, Ltd. (2395.T) on Bullrun: market cap JPY 59.24B, P/E 11.0, dividend yield 3.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2395.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyJPY
- Market capJPY 59.24B
- P/E11.0
- Dividend yield3.5%
- Financial periodFY2026
- RevenueJPY 32.52B
- Revenue growth0.3%
- Net incomeJPY 4.57B
- Free cash flowJPY 2.99B
- Gross margin49.9%
Valuation Snapshot
latest market cap is JPY 59.24B; P/E is 11.0; dividend yield is 3.5%.
Peer valuation comparison
Latest P/E is 11.04x versus a Healthcare sector median of 21.69x (49.1% below).
Latest dividend yield is 3.5% versus a Healthcare sector median of 2.41% (45.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 32.52B | JPY 4.57B | JPY 2.99B | 49.9% | 109.69 | JPY 18.54B | JPY 41.26B | JPY 43.12B |
| FY2025 | JPY 32.41B | JPY 4.92B | -JPY 3.90B | 52.3% | 118.29 | JPY 12.03B | JPY 34.47B | JPY 40.02B |
| FY2024 | JPY 26.45B | JPY 5.53B | -JPY 6.50B | 54.0% | 132.86 | JPY 10.27B | JPY 26.19B | JPY 34.11B |
| FY2023 | JPY 25.09B | JPY 6.06B | -JPY 951.70M | 52.0% | 145.56 | JPY 10.53B | JPY 18.76B | JPY 26.21B |
| FY2022 | JPY 17.75B | JPY 7.13B | JPY 4.34B | 54.6% | 171.2 | JPY 6.63B | JPY 9.14B | JPY 19.56B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 59.24B | 11.0 | 3.5% | 50 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 50 JPY, yield 3.5%.
| Year | Dividends/share |
|---|---|
| FY2026 | 50 JPY |
| FY2025 | 50 JPY |
| FY2024 | 50 JPY |
| FY2023 | 50 JPY |
| FY2022 | 0.33 JPY |
About Shin Nippon Biomedical Laboratories, Ltd.
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Shin Nippon Biomedical Laboratories, Ltd.'s market cap?
Shin Nippon Biomedical Laboratories, Ltd.'s market capitalization is JPY 59.24B.
What is Shin Nippon Biomedical Laboratories, Ltd.'s P/E ratio?
Shin Nippon Biomedical Laboratories, Ltd.'s price-to-earnings (P/E) ratio is 11.0.
Does Shin Nippon Biomedical Laboratories, Ltd. pay a dividend?
Shin Nippon Biomedical Laboratories, Ltd. has a dividend yield of 3.5%.
What does Shin Nippon Biomedical Laboratories, Ltd. do?
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies.